Effect of scheduling tramadol as a controlled substance on poison center exposures to tramadol

Annals of Pharmacotherapy

Volumn 44, Issue 6, 2010, Pages 1016-1021

  Spiller, Henry A ^a   Scaglione, J M ^b   Aleguas, Alfred ^c   Foster, Howell ^d,e   Durback Morris, Lynn ^f   Scharman, Elizabeth J ^f,g   Baker, S David ^h  

^a KENTUCKY REGIONAL POISON CENTER   (United States)

^b Cincinnati Drug and Poison Information Center   (United States)

^c Northern Ohio Poison Center   (United States)

^d Arkansas Poison and Drug Information Center   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f West Virginia Poison Center   (United States)

^g WEST VIRGINIA UNIVERSITY   (United States)

^h NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Controlled substance; Scheduled drug; Tramadol

Indexed keywords

TRAMADOL;

ARTICLE; DRUG ABUSE; DRUG DOSE REGIMEN; DRUG INTOXICATION; HUMAN; MAJOR CLINICAL STUDY; POISON CENTER; PRIORITY JOURNAL; UNITED STATES;

ARKANSAS; DATABASES, FACTUAL; DRUG AND NARCOTIC CONTROL; HUMANS; KENTUCKY; OHIO; POISON CONTROL CENTERS; TRAMADOL; WEST VIRGINIA;

EID: 77952908783     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P064     Document Type: Article

References (10)

1. Schneider MF, Bailey JE, Cicero TJ, et al. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf 2009;18:778-790
2. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300:2613-2620.
3. Clark HW. Policy and the medical-legal issues in the prescribing of controlled substances. J Psychoactive Drugs 1991;23:321-328
4. Wang J, Christo PJ. The influence of prescription monitoring programs on chronic pain management. Pain Physician 2009;12:507-515
5. Adams EH, Breiner S, Cicero TJ, Geller A, et al. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Sympt Manage 2006;31:465-476 (Pubitemid 43744403)
6. Reeves RR, Liberto V. Abuse of combinations of carisoprodol and tramadol. South Med J 2001;94:512-514
7. Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Heard SE. 2007 Annual report of the American Association of Poison Control Centers' national poison data system (NPDS):25th annual report. Clin Toxicol 2008:46:927-1057.
8. Primm BJ, Perez L, Dennis GC, et al. Managing pain: the challenge in underserved populations: appropriate use versus abuse and diversion. J Natl Med Assoc 2004;96:1152-1161 (Pubitemid 39220339)
9. T Jung B, Reidenberg MM. The risk of action by the Drug Enforcement Administration against physicians prescribing opioids for pain. Pain Med 2006;7:353-357
10. Altilio T. Pain and symptom management clinical, policy, and political perspectives. J Psychosoc Oncol 2006;24:65-79. (Pubitemid 44156052)